Enzon Pharmaceuticals Inc (OTCMKTS:ENZN)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.24 and traded as high as $0.25. Enzon Pharmaceuticals shares last traded at $0.22, with a volume of 10,436 shares trading hands.
The company has a market capitalization of $10.08 million, a price-to-earnings ratio of 1.77 and a beta of 0.06. The business’s 50-day simple moving average is $0.26 and its 200-day simple moving average is $0.24.
About Enzon Pharmaceuticals (OTCMKTS:ENZN)
Enzon Pharmaceuticals, Inc, together with its subsidiaries, engages in licensing drug products. Its marketed drug products include PegIntron for use in the treatment of chronic hepatitis C; and Sylatron for use in the treatment of melanoma disease. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Featured Story: Market Timing – The Benefits and the Danger
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.